390 related articles for article (PubMed ID: 11407658)
1. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.
Stratakis CA
J Endocrinol Invest; 2001 May; 24(5):370-83. PubMed ID: 11407658
[TBL] [Abstract][Full Text] [Related]
2. A concise genetic and clinical guide to multiple endocrine neoplasias and related syndromes.
Stratakis CA; Ball DW
J Pediatr Endocrinol Metab; 2000 May; 13(5):457-65. PubMed ID: 10803862
[TBL] [Abstract][Full Text] [Related]
3. Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.
DeLellis RA
Lab Invest; 1995 May; 72(5):494-505. PubMed ID: 7745945
[No Abstract] [Full Text] [Related]
4. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
5. [Multiple endocrine neoplasia].
Takami H; Ikeda Y; Kameyama K
Gan To Kagaku Ryoho; 2002 Apr; 29(4):508-11. PubMed ID: 11977533
[TBL] [Abstract][Full Text] [Related]
6. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
7. [Multiple endocrine neoplasia: a clinical model for applying molecular genetic techniques].
Wohllk N; Becker P; Véliz J; Pineda G
Rev Med Chil; 2000 Jul; 128(7):791-800. PubMed ID: 11050843
[TBL] [Abstract][Full Text] [Related]
8. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
9. Ovarian tumors associated with multiple endocrine neoplasias and related syndromes (Carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowden's disease).
Papageorgiou T; Stratakis CA
Int J Gynecol Cancer; 2002; 12(4):337-47. PubMed ID: 12144681
[TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia type 1 and 2: from morphology to molecular pathology 1997.
Komminoth P
Verh Dtsch Ges Pathol; 1997; 81():125-38. PubMed ID: 9474863
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia.
Calender A; Giraud S; Schuffenecker I; Lenoir GM; Gaudray P; Courseaux A; Porchet N; Aubert JP; Zhang CX
Horm Res; 1997; 47(4-6):199-210. PubMed ID: 9167953
[TBL] [Abstract][Full Text] [Related]
12. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN
J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600
[TBL] [Abstract][Full Text] [Related]
13. Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes.
Stratakis CA
Front Biosci; 2000 Mar; 5():D353-66. PubMed ID: 10704431
[TBL] [Abstract][Full Text] [Related]
14. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
15. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)].
Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H
Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
17. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
Kambouris M; Jackson CE; Feldman GL
Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
[TBL] [Abstract][Full Text] [Related]
19. RET activation by germline MEN2A and MEN2B mutations.
Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
Eng C; Crossey PA; Mulligan LM; Healey CS; Houghton C; Prowse A; Chew SL; Dahia PL; O'Riordan JL; Toledo SP
J Med Genet; 1995 Dec; 32(12):934-7. PubMed ID: 8825918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
